Division of Infectious Diseases, Department of Medicine, University Medical Center Freiburg, Germany.
Clin Microbiol Infect. 2010 Jun;16(6):533-40. doi: 10.1111/j.1469-0691.2010.03213.x.
Enterococcus faecalis and Enterococcus faecium have emerged as multi-resistant nosocomial pathogens in immunocompromised and critically ill patients. Multi-resistant strains have acquired virulence genes resulting in hospital-adapted clones. The following review summarizes several proteins and carbohydrate- or glycoconjugates that have been identified as putative virulence factors involved in the pathogenesis of enterococcal infections and may be used as targets for alternative therapies. Several studies describing the host immune response against enterococci are also summarized.
屎肠球菌和粪肠球菌已成为免疫功能低下和重症患者的多药耐药医院病原体。多药耐药株获得了毒力基因,导致医院适应克隆。以下综述总结了几种被认为是参与肠球菌感染发病机制的潜在毒力因子的蛋白质和碳水化合物或糖缀合物,并可能被用作替代治疗的靶点。还总结了几篇描述宿主对肠球菌的免疫反应的研究。